scholarly article | Q13442814 |
P50 | author | John Najarian | Q6250133 |
P2093 | author name string | R. L. Simmons | |
D. E. Sutherland | |||
R. M. Ferguson | |||
J. J. Rynasiewicz | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cyclosporine | Q367700 |
P304 | page(s) | 175-182 | |
P577 | publication date | 1982-08-01 | |
P1433 | published in | Surgery | Q15731526 |
P1476 | title | Cyclosporin A in renal transplantation: a prospective randomized trial | |
P2283 | uses | randomized experiment | Q1231081 |
P478 | volume | 92 |
Q69882688 | A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients |
Q41105613 | Cadaveric Renal Transplantation With Cyclosporin-A and Steroids. |
Q37310997 | Cadaveric renal transplantation under cyclosporine-steroid therapy |
Q54258058 | Comparison of Azathioprine-Antilymphocyte Globulin versus Cyclosporine in Renal Transplantation |
Q69897143 | Cyclosporin A effective therapy for fifty-two cadaver kidney recipients |
Q70302607 | Cyclosporin a used alone or in combination with low-dose steroids in cadaveric renal transplantation |
Q72571746 | Cyclosporin and blood transfusion in kidney transplantation |
Q40918376 | Cyclosporin clinical pharmacokinetics |
Q33993493 | Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplants |
Q72403146 | Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients |
Q40834086 | Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. |
Q70386814 | Experience with cyclosporine and steroids in clinical renal transplantation |
Q68196997 | Graft survival and long-term renal function after sequential conventional cyclosporin A therapy in cadaver kidney transplantation--a prospective randomized trial |
Q68953653 | Immunotoxicity of immunotherapeutic agents |
Q72571749 | Is the loin pain and haematuria syndrome a renal manifestation of hypersensitivity? |
Q40159228 | Laryngeal transplantation: research, clinical experience, and future goals |
Q68796438 | Liver injury from cyclosporine A |
Q88644275 | Multitarget Therapy for Maintenance Treatment of Lupus Nephritis |
Q40267687 | Pancreas and islet transplantation |
Q30239091 | Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. |
Q72304467 | Primary care of the renal transplant patient |
Q41872114 | Second Cadaver Kidney Transplants: Improved Graft Survival in Secondary Kidney Transplants Using Cyclosporin A |
Q34497811 | Steps in immunosuppression for renal transplantation |
Q34330601 | The development of clinical renal transplantation |
Q43756407 | The third kidney transplant |
Q34805943 | The timing of introduction of pharmaceutical innovations in seven European countries |
Q72326289 | Triple immunosuppression with subsequent prednisolone withdrawal: 6 years' experience in paediatric renal allograft recipients |
Q44010095 | Use and limits of preventive antilymphocyte globulin therapy following kidney transplantation. A prospective randomized study |
Search more.